India is growing rapidly in pharmaceutical sector; there is a need of PRA specialists to cater to the current needs of industries as the global competition is increasing. Regulatory affairs specialists are the link between pharmaceutical industries and world-wide regulatory agencies and are required to be well versed with laws, regulations and guidelines as per different regulatory agencies. There is a growing need to incorporate the current requirements of pharmaceutical industries in the curriculum of pharmacy to prepare the students with the latest developments to serve the industries.
Pharmaceutical Regulatory Affairs (PRA) course is started in the year 2010 in the Department of Pharmaceutics. The PRA is a comparatively new & specialized discipline, which has developed to protect public health, by controlling the safety and efficacy of products which includes pharmaceuticals, veterinary medicines, medical devices, pesticides, agrochemicals, cosmetics and complementary medicines. PRA department in a pharmaceutical company is a vital unit that drives the R & D efforts of the company to the market successfully. The regulatory department works with a focus to get products to the market with a commercially viable label, in the least possible time and expense.
To make JSS College of Pharmacy, Mysuru a preferred destination to study Pharmaceutical Regulatory Affairs
To make available a pool of competent professionals in the area of Pharmaceutical Regulatory Affairs with fundamental knowledge on various Good Regulatory Practices in the Health care and related industries
To make available a pool of competent professionals in the area of Pharmaceutical Regulatory Affairs with fundamental knowledge on
Asia has emerged as a strong growth region for the pharmaceutical industry in recent years, in particular India, which is fast becoming a preferred location for clinical trials and research and development activities. The creation of a new product patent system in 2005 was a driver of this growth, which is expected to increase as the domestic market in India further opens up. This growth has also helped facilitate an increasing number of pharma regulatory affairs jobs in India. A number of companies have set up in the most populous city in the country, creating a number of regulatory affairs jobs in Mumbai. Figures from www.companiesandmarkets.com report show that by the year 2012 the market for clinical trials in India is expected to grow to $630 million (£404 million), helped by the fact that the cost of conducting research in the country is sometimes less than half that in more developed nations.